We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GORO icon
2176
Goldgroup Mining Inc.
GORO
$211M
$119K ﹤0.01%
28,915
CNR
2177
DELISTED
Cornerstone Building Brands, Inc.
CNR
$119K ﹤0.01%
19,586
LOVE
2178
LoveSac
LOVE
$253M
$118K ﹤0.01%
+4,517
New +$68.7K
BWB icon
2179
Bridgewater Bancshares
BWB
$614M
$118K ﹤0.01%
11,530
PKE icon
2180
Park Aerospace
PKE
$828M
$118K ﹤0.01%
10,569
HOFT icon
2181
Hooker Furnishings Corp
HOFT
$160M
$117K ﹤0.01%
6,029
+585
+11% +$9.36K
CLDT
2182
Chatham Lodging
CLDT
$590M
$117K ﹤0.01%
19,109
KRO icon
2183
KRONOS Worldwide
KRO
$905M
$117K ﹤0.01%
11,199
SITM icon
2184
SiTime
SITM
$20.5B
$116K ﹤0.01%
+2,453
New +$72.8K
SI
2185
DELISTED
Silvergate Capital Corporation
SI
$116K ﹤0.01%
+8,281
New +$112K
EIGR
2186
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$116K ﹤0.01%
+402
New +$118K
GRWG icon
2187
GrowGeneration
GRWG
$107M
$116K ﹤0.01%
+16,935
New +$93.2K
ISEE
2188
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$116K ﹤0.01%
+22,703
New +$94.6K
FNLC icon
2189
First Bancorp
FNLC
$402M
$115K ﹤0.01%
5,308
FULC icon
2190
Fulcrum Therapeutics
FULC
$284M
$115K ﹤0.01%
+6,267
New +$98.7K
WLDN icon
2191
Willdan Group
WLDN
$1.29B
$114K ﹤0.01%
4,570
EGAN icon
2192
eGain
EGAN
$200M
$114K ﹤0.01%
+10,272
New +$93.5K
AKTS
2193
DELISTED
Akoustis Technologies Inc
AKTS
$114K ﹤0.01%
+13,764
New +$106K
CAMP
2194
DELISTED
CalAmp Corp.
CAMP
$114K ﹤0.01%
619
MNOV icon
2195
MediciNova
MNOV
$65.5M
$114K ﹤0.01%
+21,034
New +$112K
LDL
2196
DELISTED
Lydall, Inc.
LDL
$114K ﹤0.01%
+8,394
New +$92.9K
NWPX icon
2197
NWPX Infrastructure Inc
NWPX
$1.1B
$114K ﹤0.01%
4,538
IVC
2198
DELISTED
Invacare Corporation
IVC
$113K ﹤0.01%
17,816
SPNE
2199
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$113K ﹤0.01%
+10,839
New +$111K
GME icon
2200
GameStop
GME
$8.32B
$113K ﹤0.01%
104,284

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.